The short version
14 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Levetiracetam · LEVETIRACETAM 5 mg/mL · Injection · Intravenous · Gland Pharma Limited
NDC 68083-0152-10 · 10 BAG in 1 CARTON / 100 mL in 1 BAG · ANDA · View full market →
14 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Armas Pharmaceuticals Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Civica, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Method Pharmaceuticals, LLC | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Nexus Pharmaceuticals LLC | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Nexus Pharmaceuticals LLC | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Nexus Pharmaceuticals LLC | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | LEVETIRACETAM 15 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | LEVETIRACETAM 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| WG Critical Care, LLC | LEVETIRACETAM 10 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Levetiracetam — NDC 68083-0152-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68083015210.
Free to cite with attribution — see how the data is put together.